I guess we’ll just need to wait and see what the board announces.
What I find more fascinating though, Walhall, is your level of expertise on clinical trials. You don’t have prior experience in this area do you, perhaps as a founder of this company? Do tell.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.